About this trial
The aim of this clinical trial is to determine if trans-auricular vagus nerve stimulation (taVNS) is effective in improving upper extremity function in stroke survivors. The primary objectives include: Investigating whether taVNS improves motor function in stroke survivors. The secondary objectives include: Assessing any potential side effects associated with the method. Investigating taVNS effects on daily routine functions and spasticity Researchers will conduct a comparative analysis between taVNS and a sham procedure (which mimics the stimulation without any actual effect) to assess its effectiveness. Participants in the trial will: Undergo taVNS combined with physical therapy or a sham procedure with physical therapy daily over a two-week period.
Eligibility criteria
Qualifiers
None
Disqualifiers
Patients with any contraindication to taVNS, peripheral upper extremity injuries, use of medication affecting cortical excitability in the past 3 months, use of botulinum toxin in the past 3 months, presence of any other neurological disorder, or significant cognitive deficits.
Trial design
Treatments tested in this trial
- Active taVNS
- Sham taVNS
Treatment groups
Sponsors and collaborators
Universidade Federal de Pernambuco
Lead sponsor
Fundação de Amparo à Ciência e Tecnologia de Pernambuco
Collaborator
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Collaborator